
Number of publications published per year by Liang, T. Jake. (Source : PubMed)

Distribution of publications types for Liang, T. Jake. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)

Novel function of CD81 in controlling hepatitis C virus replication.
J. Virol.
2010;84;7
Ribavirin improves early responses to peginterferon through enhanced interferon signaling.
Gastroenterology
2010
Clinical trial: low- and standard-dose peginterferon alfa-2a for chronic hepatitis C, genotype 2 or 3 - efficacy, tolerability, viral kinetics and cytokine response.
Aliment. Pharmacol. Ther.
2010
Increased caffeine consumption is associated with reduced hepatic fibrosis.
Hepatology
2010;51;1
Natural killer cells are polarized toward cytotoxicity in chronic hepatitis C in an interferon-alfa-dependent manner.
Gastroenterology
2010;138;1



Reactivation of hepatitis B with reappearance of hepatitis B surface antigen after chemotherapy and immunosuppression.
Clin. Gastroenterol. Hepatol.
2009;7;10


A genome-wide genetic screen for host factors required for hepatitis C virus propagation.
Proc. Natl. Acad. Sci. U.S.A.
2009;106;38



Amphipathic DNA polymers inhibit hepatitis C virus infection by blocking viral entry.
Gastroenterology
2009;137;2

Coinfection with hepatitis C virus and human immunodeficiency virus: virological, immunological, and clinical outcomes.
J. Virol.
2009;83;15

Acute hepatitis C.
Gastroenterology
2009;136;7
[ See timeline ] [ See all publications ]
means that Liang, T. Jake has 50 papers cited a least 50 times - methodology
Liver Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, 10 Center Drive, Rm. 9B16, Bethesda, MD 20892-1800, USA.
Due mainly to homonyms, errors are possible and if you detect "false positives" or "false negatives" don't be too frustrated and please contact the webmaster.